IONIQ HEALTH
LIVE

Serial Number

97698996

Owner

Moda Partners, Inc.

Attorney

ERNEST G. BOOTSMA

Filing Date

Dec 1, 2022

Add to watchlist:

No watchlists yet
View on USPTO

IONIQ HEALTH Trademark

Serial Number: 97698996

IONIQ HEALTH is a trademark filed by Moda Partners, Inc. on December 1, 2022. The trademark is classified under Class 36 (Insurance & Financial), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Moda Partners, Inc.

601 SW Second Ave
Portland, OR 97204

Entity Type: 03

Trademark Details

Filing Date

December 1, 2022

Registration Date

Not Registered

Goods & Services

Drug utilization review in the nature of providing medical research information for educating about proper medication utilization to medical, pharmaceutical, and dental providers, patients and members; medical research in the fields of drug utilization review for drug interactions, duplication of drug therapy, contraindications; medical research in the field of drug utilization review in the nature of drug interactions and contraindications

Business management, business administration, marketing and promotion of pharmacies and infusion centers for patients with particular medical conditions; coordination and support of the delivery of pharmacy and infusion services, namely, arranging managed care services in the fields of durable medical equipment and specialty pharmacy supplies; pharmaceutical cost management services for others, namely, business data reporting and analytics to others in the field of drug utilization review; business administration services, namely, coordination of prescription medication fulfillment to pharmacies to establish pharmacy networks for health care providers, patients, and members for controlling drug inventories

Pharmaceutical and medical benefit management services; reimbursement payment processing in the fields of pharmaceutical and medical claims; providing financial information relating to drug pricing and actuarial services to others; pharmacy network management in the nature of monitoring financial performance of pharmacies for the purpose of measuring and reporting on the cost of pharmaceutical and medical networks to others

Clinical pharmacy services for pharmacy and infusion therapy patients with certain medical conditions; pharmacy advice and counseling for pharmacy and infusion therapy patients; preparation of prescriptions in pharmacy and infusion centers, hospitals and medical clinics; medication therapy management services for individuals in the nature of checking medication compliance and medication counseling

Filing History

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
May 31, 2026 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Sep 12, 2025 RCSC
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Sep 11, 2025 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Mar 10, 2025 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Feb 6, 2025 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jun 26, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Jun 26, 2024 GNSL
SUSPENSION LETTER WRITTEN
Jun 26, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 27, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 26, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 26, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Dec 1, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Dec 1, 2023 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 26, 2023 GNRN
NON-FINAL ACTION E-MAILED
Sep 26, 2023 GNRT
NON-FINAL ACTION WRITTEN
Sep 26, 2023 CNRT
ASSIGNED TO EXAMINER
Sep 11, 2023 DOCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 17, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 17, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 17, 2023 REAP
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 27, 2022 NWOS
NEW APPLICATION ENTERED
Dec 5, 2022 NWAP